Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation

NCT01028092 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT01028092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01028092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation
Lead sponsor
University Hospital, Brest
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2009
Completion date
July 31, 2014
Enrollment
327 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

renal transplant